Heart Failure Gene Therapy
Open Access
- 30 August 2013
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation Research
- Vol. 113 (6), 792-809
- https://doi.org/10.1161/circresaha.113.300269
Abstract
Gene therapy, aimed at the correction of key pathologies being out of reach for conventional drugs, bears the potential to alter the treatment of cardiovascular diseases radically and thereby of heart failure. Heart failure gene therapy refers to a therapeutic system of targeted drug delivery to the heart that uses formulations of DNA and RNA, whose products determine the therapeutic classification through their biological actions. Among resident cardiac cells, cardiomyocytes have been the therapeutic target of numerous attempts to regenerate systolic and diastolic performance, to reverse remodeling and restore electric stability and metabolism. Although the concept to intervene directly within the genetic and molecular foundation of cardiac cells is simple and elegant, the path to clinical reality has been arduous because of the challenge on delivery technologies and vectors, expression regulation, and complex mechanisms of action of therapeutic gene products. Nonetheless, since the first demonstration of in vivo gene transfer into myocardium, there have been a series of advancements that have driven the evolution of heart failure gene therapy from an experimental tool to the threshold of becoming a viable clinical option. The objective of this review is to discuss the current state of the art in the field and point out inevitable innovations on which the future evolution of heart failure gene therapy into an effective and safe clinical treatment relies.Keywords
This publication has 111 references indexed in Scilit:
- Comparison of Adeno-Associated Virus Serotypes and Delivery Methods for Cardiac Gene TransferHuman Gene Therapy Methods, 2012
- Prospects for gene transfer for clinical heart failureGene Therapy, 2012
- AAV6-βARKct gene delivery mediated by molecular cardiac surgery with recirculating delivery (MCARD) in sheep results in robust gene expression and increased adrenergic reserveThe Journal of Thoracic and Cardiovascular Surgery, 2012
- AAV Vectors for Cardiac Gene Transfer: Experimental Tools and Clinical OpportunitiesMolecular Therapy, 2011
- S100A1 in cardiovascular health and disease: Closing the gap between basic science and clinical therapyJournal of Molecular and Cellular Cardiology, 2009
- VEGF Gene Therapy Fails to Improve Perfusion of Ischemic Myocardium in Patients With Advanced Coronary Disease: Results of the NORTHERN TrialMolecular Therapy, 2009
- Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID Trial), a First-in-Human Phase 1/2 Clinical TrialJournal of Cardiac Failure, 2009
- Gene network dynamics controlling keratinocyte migrationMolecular Systems Biology, 2008
- Non-invasive radioiodine imaging for accurate quantitation of NIS reporter gene expression in transplanted hearts☆☆☆European Journal of Cardio-Thoracic Surgery, 2008
- Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteinsJournal of Molecular and Cellular Cardiology, 2007